Skip to content
Agentic OS
Menu

Intelligence / Healthtech / FDA 510(k) Clearances / Levo Medical Corporation

Approvalsdevice cleared13 Aug 2026

Levo Medical Corporation

13 Aug 2026: Device cleared · Levo Gen 2 Tinnitus Therapy System. Recorded in the openFDA device 510(k) data.

View the source record

Decided
13 Aug 2026
Device
Levo Gen 2 Tinnitus Therapy System
Specialty
Ear, Nose, Throat
Country
Canada
Location
Victoria, Bc
Clearance type
Traditional
510(k) number
K260413
Submitted
2026-02-09
What this signal means

A clearance starts commercialisation: distribution, reimbursement, software and sales hires.

  1. 268 added in the 30 days to 9 Nov 2026.
  2. Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS

Find the decision makers at Levo Medical Corporation

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

More in Ear, Nose, Throat

FDA 510(k) Clearances

See all

Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.